As our research uncovers more subtypes and personalised treatments, clear communication about biomarkers with patients is increasingly crucial. Our global survey with ABC Global Alliance emphasises the need to empower people living with metastatic breast cancer with knowledge about biomarkers to engage in their care decisions. To learn more visit: https://learn.az/6048gBOaY
AstraZeneca
Pharmaceutical Manufacturing
Cambridge, Cambridgeshire 2,931,834 followers
What science can do
About us
We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio
- Website
-
http://www.astrazeneca.com
External link for AstraZeneca
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001 employees
- Headquarters
- Cambridge, Cambridgeshire
- Type
- Public Company
- Specialties
- Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business
Locations
-
Primary
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge, Cambridgeshire CB2 0AA, GB
-
Astraallen
Sodertalje, Stockholm County 152 57, SE
Employees at AstraZeneca
Updates
-
The Cambodia Breast Cancer Initiative is just one way we have collaborated with Americares since 2003. Thanks to the partnership more than 100,000 Cambodian women were reached with information, and 10,000 women were screened for breast cancer. Find out more here: https://learn.az/60459XceS #GlobalHealth #HealthcareForAll #PatientHealth
-
This recent publication in Nature Metabolism on preclinical disease models that better reflect Metabolic dysfunction-Associated Steatohepatitis (MASH) in humans aims to increase success of future clinical trials. It highlights a milestone in our collaboration with the LITMUS Project, of which we have been a member for several years. The LITMUS Project is a public-private partnership dedicated to advancing vital research efforts aimed at tackling MASH. Learn more here: https://learn.az/604891Kxn
-
We're thrilled to announce that for the second year in a row we have maintained our Gold rating for EcoVadis, the globally recognised sustainability rating platform. This achievement reflects our commitment to driving sustainability from lab to patient. Evaluating our performance in four key areas: environment, ethics, labour and human rights, and sustainable procurement, the result places us in the top 3% of all rated companies. Through our ambitious sustainability strategy, we’re focused on delivering positive impact for people, society and planet. Find out more in our Sustainability Impact publication: https://learn.az/6040goA2m #WhatScienceCanDo #Ecovadis 🌿 🌍
-
We're motivated by patients and our partners to address the realities of GI cancers and drive breakthroughs for those in need. We believe in inclusivity to help us reach our bold goal and look forward to working alongside members of the GI cancer community at #ESMOGI24 to revolutionise GI cancer care.
-
We have joined forces with International Gynecologic Cancer Society and their Advocacy Network, IGCAN, to share the stories of inspiring women impacted by uterine cancer around the world. Access the full video here https://learn.az/6048gdRJm #UterineCancerAwarenessMonth #EndometrialCancer #WombCancer
Uterine Cancer Awareness Month
-
We're dedicated to improving health outcomes through a concerted focus on climate action, health systems resilience and equity. Learn why five of our next generation leaders are passionate about this agenda and find out about their impactful work for people, society and the planet. Access the full series on YouTube here: https://learn.az/6043gb72L #WhatScienceCanDo Elishia Alleyne, Kate Stevenson, Talita Gobbi, mohamed khamis
-
Advances in cell therapy are transforming cancer treatment; however, their revolutionary status leads to unique challenges for existing regulatory frameworks. We’re collaborating with regulators internationally to help shape frameworks that support patient access to these new, transformative cell therapies in oncology. Learn more here: https://lnkd.in/esC9hQuW #WhatScienceCanDo #RegulatoryFrameworks #CellTherapy
Collaboration in cell therapy regulation | AstraZeneca
astrazeneca.com
-
Identifying the right treatment for each patient relies on biomarker testing. Partnering with ABC Global Alliance, we conducted a global study to understand the challenges people with metastatic breast cancer face when learning about their biomarkers. Learn how new treatment approaches and clear information can improve patient experience: https://learn.az/6041gBOoP
-
Personalised cancer treatments have significantly advanced patient survival and quality of life after diagnosis. Innovation and support from medical, patient and caregiver communities allow patients such as Jeff to live their lives with less limitations than ever thought possible. Discover Jeff’s full story as a six-year survivor of Stage IV lung cancer here: https://learn.az/60415qzzX #NationalCancerSurvivorMonth #CelebrateSurvivorship #ASCO24